跳到正文
原文
NICE· @NICEComms · X·· 5 小时前精选AI 评分42
AI 导读

NICE表示,其与MHRA的同步审评路径正在加速推进,首个药品预计今年完成整个流程。该路径将药品许可与价值评估的决策同步进行,并整合科学建议,NICE发布了关于其实际运行情况的更新。

推荐理由

NICE与MHRA同步审评路径的进展更新,可了解英国药品许可与价值评估并行机制的实际运行方式。

正文

The @MHRAgovuk-NICE aligned pathway is gathering pace, with the first medicine expected to complete its journey later this year.

Read our update on how same time decisions on licencing and value, and integrated scientific advice, are working in practice: https://www.nice.org.uk/news/blogs/mhra-and-nice-aligned-pathway-how-it-s-working-in-practice?utm_medium=organic&utm_source=x&utm_campaign=alignedpathway_300926&utm_content=graphic

来源:NICE · x.com